Protara Therapeutics Financial Overview
Protara Therapeutics's market cap is currently $286.55M. The company's EPS TTM is $-0.31; its P/E ratio is -3.85; Protara Therapeutics is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-0.35. See an overview of income statement, balance sheet, and cash flow financials.
